Navigation Links
Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
Date:2/6/2013

RICHMOND, Calif., Feb. 6, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported fourth quarter and full year 2012 financial results and accomplishments.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

For the fourth quarter ended December 31, 2012, Sangamo reported a consolidated net loss of $3.5 million, or $0.07 per share, compared to a net loss of $6.4  million, or $0.12 per share, for the same period in 2011. As of December 31, 2012, the Company had cash, cash equivalents, marketable securities and interest receivable of $76.3 million.

Revenues were $8.9 million for the fourth quarter of 2012, compared to $4.7 million for the same period in 2011.  Fourth quarter 2012 revenues were generated from the Company's collaboration agreements with Shire AG (Shire), Dow AgroSciences (DAS) and Sigma-Aldrich Corporation (Sigma), and research grants. The revenues recognized for the fourth quarter of 2012 consisted of $8.5 million in collaboration agreements and $0.4 million in research grants, compared to $3.2 million and $1.5 million, respectively, for the same period in 2011.

The increase in collaboration agreement revenues was primarily due to the Company's collaboration and license agreement with Shire established in January 2012.  Pursuant to the agreement, Sangamo received an upfront payment of $13.0 million, which is being amortized on a straight-line basis over the initial six-year research term, of which the Company recognized $0.5 million as revenue for the fourth quarter of 2012. Sangamo also recognized $4.3 million of revenues related to research services performed under the collaboration agreement with Shire in the fourth quarter. The increase in collaboration agreement revenues for the fourth quarte
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
2. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
3. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
5. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
6. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
7. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
8. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
9. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
10. Pressure BioSciences Partners with Constant Systems to Significantly Expand Product Offerings and International Distribution
11. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
(Date:5/21/2013)... , May 21, 2013   Accuray ... today the publication of study results involving hundreds ... Robotic Radiosurgery System, the most widely used form ... study followed 304 patients for a median of ... and found that 97 percent of patients with ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... MIRAGE, Calif., March 27 In the medical,community at ... attacks kill,and destroy cells in the heart muscle. Multiple ... stimulate the heart to repair,itself after an individual suffers ... The Weil Institute of Critical Care Medicine, located in ...
... Discovery Support Program, HAMBURG, Germany and ... (Frankfurt Stock Exchange: EVT) announced today that ... Japan) signed a new drug,discovery agreement targeting ... collaboration applies Evotec,s proprietary fragment-based drug,discovery platform, ...
Cached Medicine Technology:Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 3
(Date:5/21/2013)... risk of sudden infant death syndrome (SIDS) is five ... new study finds. British researchers noted that bed-sharing ... not drink, use illegal drugs or smoke. They advised ... of infant death in developed countries, would drop dramatically ... In the United States, all parents are advised to ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... 2013 Residents in St. Petersburg, FL ... now that Dr. David Sherberg, DMD, has joined Coast ... Dr. Sherberg provides preventive, restorative and cosmetic dentistry to ... friendly team provide a wide variety of services ... canal therapy, crowns, bridges, dentures, dental implant restorations, veneers, ...
(Date:5/21/2013)... TheBeautyPlace.com helps brides to breathe a little easier ... Kit including all the essentials a glowing bride or ... Wedding Day. , TheBeautyPlace.com features Wedding Day essentials to ... Day. Flowers blooming and warmer weather indicates the springtime, ... Memorial Day to October, brides to be can finally ...
(Date:5/21/2013)... Dr. Francine Kaufman , inventor of Extend ... patients in the 1980s: It weighed several pounds and was jokingly ... it could only be used in the hospital setting. , The ... the advantages are greater as well. The insulin pump is now ... often on a belt or a pocket. It delivers fast-acting insulin ...
Breaking Medicine News(10 mins):Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4
... A group ... Jackson Healthcare. The Hospital Charitable Service Awards have been created to find and celebrate ... ... A group of senior healthcare executives have joined forces to launch a new awards program ...
... BOSTON (May 25, 2010) Longtime environmental health ... the carcinogenic effects of endocrine-disrupting chemicals (EDCs), ubiquitous ... In a review article published online May 25 ... express the need for more complex strategies for ...
... a new influenza vaccine that brings science one step closer ... for seasonal flu shots. The new findings can be ... first online, open-access journal published by the American Society for ... narrow range of influenza virus strains," said Peter Palese, Ph.D., ...
... Suggestions include ,presumed consent, and priority for those who pledge ... transplants save thousands of lives every year, but many more ... of organs. While proposals to increase the supply have ... -- or even if they should be tried at all. ...
... ... and earn money for college, by entering the B’nai B’rith International Diverse Minds Youth ... grade-schoolers about tolerance and diversity. The winners take home $5,000 college scholarships and will ... ...
... Arnhem -- On 8 May an editorial about the Reduction ... H. Schrder and Monique J. Roobol was published in the ... of the European Association of Urology (EAU). The ... 1, 2010 in the New England Journal of Medicine ...
Cached Medicine News:Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 2Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 3Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 4Health News:Endocrine-disrupting chemicals pose cancer risk 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 3Health News:High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published 2Health News:European Urology: Editorial about REDUCE trial underlines value of dutasteride 2
... ago, Zyderm® and Zyplast® injectable collagen implants ... for smoothing facial lines, wrinkles and scars ... supplement the skins natural collagen, require minimal ... more than one million people worldwide have ...
... Captique is a non-animal stabilized ... newest HA filler to enter the ... correction of moderate to severe facial ... folds). Captique is injected just under ...
... Radiesse brings you into the new ... can now offer your patients immediate, long-term ... and flexibility. This injectable filler offers superior ... cosmetic and reconstructive treatments. Long-lasting, Radiesse saves ...
The HEMOCHRON Model 401 is a portable, single-well whole blood coagulation monitoring instrument. The 401 provides on-screen plasma equivalent PT and APTT test results....
Medicine Products: